Kinetics of Targeted Phage Rescue in a Mouse Model of SystemicEscherichia coliK1
Open Access
- 11 July 2018
- journal article
- research article
- Published by Wiley in BioMed Research International
- Vol. 2018, 1-8
Abstract
Escherichia (E.) coliK1 strains remain common causative agents of neonatal sepsis and meningitis. We have isolated a lytic bacteriophage (ΦIK1) againstE. colistrain IHE3034 and tested its specificityin vitro, as well as distribution and protective efficacyin vivo. The phage was shown to be specific to the K1 capsular polysaccharide. In the lethal murine model, a high level of protection was afforded by the phage with strict kinetics. A single dose of 1 x 108phage particles administered 10 and 60 minutes following the bacterial challenge elicited 100 % and 95 % survival, respectively. No mice could be rescued if phage administration occurred 3 hours postinfection. Tissue distribution surveys in the surviving mice revealed that the spleen was the primary organ in which accumulation of active ΦIK1 phages could be detected two weeks after phage administration. These results suggest that bacteriophages have potential as therapeutic agents in the control of systemic infections.Keywords
This publication has 26 references indexed in Scilit:
- AsrR Is an Oxidative Stress Sensing Regulator Modulating Enterococcus faecium Opportunistic Traits, Antimicrobial Resistance, and PathogenicityPLOS Pathogens, 2012
- Bacteriophage Host Range and Bacterial Resistance2010
- Efficacy of Bacteriophage Treatment in Murine Burn Wound Infection Induced by Klebsiella pneumoniaeJournal of Microbiology and Biotechnology, 2009
- Therapeutic potential of bacteriophage in treating Klebsiella pneumoniae B5055-mediated lobar pneumonia in miceJournal of Medical Microbiology, 2008
- The RAST Server: Rapid Annotations using Subsystems TechnologyBMC Genomics, 2008
- Experimental Phage Therapy against Staphylococcus aureus in MiceAntimicrobial Agents and Chemotherapy, 2007
- Phage Therapy of Pseudomonas aeruginosa Infection in a Mouse Burn Wound ModelAntimicrobial Agents and Chemotherapy, 2007
- Common Virulence Factors and Genetic Relationships between O18:K1:H7 Escherichia coli Isolates of Human and Avian OriginJournal of Clinical Microbiology, 2006
- Bacteriophage Therapy Rescues Mice Bacteremic from a Clinical Isolate of Vancomycin-Resistant Enterococcus faeciumInfection and Immunity, 2002
- ERRATUMThe Journal of Infectious Diseases, 2001